Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,661 | 95,401 | 58,056 | 35,045 | 29,117 |
| Marketable Securities | 36,978 | 0 | 5,080 | 24,385 | 65,855 |
| Receivables | 18,981 | 16,651 | 15,049 | 14,610 | 25,457 |
| Inventories | 13,884 | 13,003 | 15,088 | 20,114 | 17,924 |
| TOTAL | $96,096 | $127,106 | $94,801 | $96,671 | $144,095 |
| Non-Current Assets | |||||
| PPE Net | 8,056 | 8,825 | 12,301 | 16,525 | 15,258 |
| Investments And Advances | 0 | 0 | 0 | 0 | 6,493 |
| Intangibles | 150,308 | 161,508 | 172,708 | 183,908 | 195,108 |
| Other Non-Current Assets | 10,352 | 6,208 | 7,541 | 9,291 | 9,096 |
| TOTAL | $168,716 | $176,541 | $192,550 | $209,724 | $225,955 |
| Total Assets | $264,812 | $303,647 | $287,351 | $306,395 | $370,050 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,152 | 4,027 | 4,211 | 3,967 | 6,094 |
| Accrued Expenses | 5,160 | 14,470 | 10,535 | 3,996 | 3,553 |
| TOTAL | $32,821 | $37,582 | $33,474 | $29,500 | $30,081 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 11,803 | 11,464 | 10,238 | 9,163 | 9,419 |
| Other Non-Current Liabilities | 58,717 | 173,908 | 201,063 | 198,207 | 197,075 |
| TOTAL | $78,379 | $193,949 | $222,942 | $223,662 | $225,068 |
| Total Liabilities | $111,200 | $231,531 | $256,416 | $253,162 | $255,149 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,446 | 68,989 | 38,812 | 29,208 | 28,844 |
| Common Shares | 70 | 49 | 39 | 29 | 29 |
| Retained earnings | -623,641 | -558,851 | -500,196 | -439,477 | -363,492 |
| Other shareholders' equity | -582 | -687 | -574 | -760 | -1,144 |
| TOTAL | $153,612 | $72,116 | $30,935 | $53,233 | $114,901 |
| Total Liabilities And Equity | $264,812 | $303,647 | $287,351 | $306,395 | $370,050 |